All that happened in the markets today
The company is also planning to enter new markets with relevant offering as part of expanding its geographical footprint, Zydus Wellness said
Zydus group firm Zydus Wellness on Friday reported a 10.94 per cent rise in consolidated net profit at Rs 89.20 crore for the quarter ended June 30, 2020. The company had posted a net profit of Rs 80.40 crore for the corresponding period of the previous year,Zydus Wellness said in a filing to BSE. Consolidated revenue from operations of the company stood at Rs 537.37 crore for the quarter under consideration, as against Rs 620.25 crore in the year-ago period, it added. The past quarter was an "unprecedented one" due to the COVID-19 pandemic impacting the company's operations in the early part of the quarter, Zydus Wellness said. "However, with the logistical challenges being resolved and approvals for re-starting manufacturing plants and operating C&FA warehouses coming in, the company was able to recover from the early setbacks,"it added. Coping with the pandemic, the company continues to be agile in its responses and execution of its plans,Zydus Wellness said. Shares of Zydus .
According to Zydus Wellness, the Covid-19 pandemic and the subsequent lockdown disrupted the supply chain and virtually no sales were reported in the later part of March 2020.
Over a year since the company acquired Complan, Glucon-D and Nycil, it is redrawing the marketing formula around its newly acquired brands
To become part of the consumer's monthly shopping cart, Sugar Free has launched new formats and variants and waged war against online venom
The company's total consolidated income from operations rose 333 per cent to Rs 620 crore from Rs 152 crore in Q1FY19
Consumer business crucial for Cadila Healthcare, at a time when US and India have pricing pressure
Heinz India, a subsidiary of the US-based Kraft Heinz, has now ceased to exist after the amalgamation of the two subsdiaries
In October 2018, Zydus Wellness had announced acquisition of Heinz India's consumer wellness business
Analysts expect acquisition to be earnings accretive in around 3 years
This is the first time a private equity player will be on Zydus' board of directors
At 10:06 am, the stock was trading at Rs 1,287.80, up 2.54 per cent from the previous close. A total of 12,672 shares exchanged hands on the counter.
Company looks for a wider berth in the country's burgeoning beauty market, redesigns and rebrands its flagship brand
The stock hit a new high of Rs 1,298, up 11% on the BSE in intra-day trade on back of heavy volumes.
With Rs 4,897 mn cash in balance sheet and a 94 per cent category share in artificial sweeteners, the company is eyeing the inorganic route to propel growth
The shares dipped marginally to Rs 880 a share on the BSE
The company had posted a net profit of Rs 27.73 crore in the same period a year ago
Gross margins increased by 140 basis points and reached 66.8 per cent
Its performance was driven by brands like Sugar Free, EverYuth and Nutralite